Affimed N.V. Competitors and Similar CompaniesClear all
Affimed N.V.'s competitors and similar companies include Array BioPharma, BTG and Tricida.
 Affimed N.V. Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |||
Founding Date | Founding Date 2000 | Founding Date 1998 | Founding Date 1948 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Heidelberg, DE HQ | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US | Locations South San Francisco, US HQ | |
Employees | Employees 76 | Employees 110 | Employees 650 | Employees 11914% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) €8.3m (FY, 2023) | Revenue (est.) $173.8m (FY, 2018) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $59.4m (FY, 2018) | Cost of goods £221m (FY, 2019) | Cost of goods N/A |
Gross profit | Gross profit €13m (FY, 2023) | Gross profit $114.4m (FY, 2018) | Gross profit £510.3m (FY, 2019) | Gross profit N/A |
Net income | Net income (€105.9m) (FY, 2023) | Net income ($147.7m) (FY, 2018) | Net income £88.3m (FY, 2019) | Net income ($176.6m) (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company
Tricida
HQ
South San Francisco, US
Employees
119↑ 14% increase
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company